LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis

The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186

(2017) Yuan Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting noncoding RNAs in disease

(2017) Brian D. Adams et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A

(2017) Wanjun Li et al.   Oncology Letters

Long noncoding RNAUPATpromotes colon tumorigenesis by inhibiting degradation of UHRF1

(2016) Kenzui Taniue et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functions and mechanisms of long noncoding RNAs in lung cancer

(2016) Chaojun Duan et al.   OncoTargets and Therapy

Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP

(2016) Ruilin Lei et al.   OncoTargets and Therapy

miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin

(2016) Yongzhou Zhang et al.   Oncology Letters

Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression

(2016) Hui-yuan Zhai et al.   MEDICAL SCIENCE MONITOR

Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205

(2015) H. Hirata et al.   CANCER RESEARCH

LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma

(2015) Haibing Xiao et al.   Oncotarget

MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET

(2014) Lijun Duan et al.   FEBS LETTERS

HMGB1 in health and disease

(2014) Rui Kang et al.   MOLECULAR ASPECTS OF MEDICINE

Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice

(2013) Rui Kang et al.   GASTROENTEROLOGY

Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high-mobility group box 1 in cellular protection

(2013) Hai Huang et al.   HEPATOLOGY

Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC

(2013) MingHua Li et al.   PLoS One

Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection

(2013) H. Yanai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells

(2012) Chunhong Wang et al.   CANCER BIOLOGY & THERAPY

Recurrent R-spondin fusions in colon cancer

(2012) Somasekar Seshagiri et al.   NATURE

Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy

(2012) Oliver J. Stoetzer et al.   TUMOR BIOLOGY

Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma

(2012) WEI WANG et al.   Oncology Letters

No-Nonsense Functions for Long Noncoding RNAs

(2011) Takashi Nagano et al.   CELL

Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies

(2010) Yikyung Park et al.   CANCER CAUSES & CONTROL

Colon cancer

(2010) Roberto Labianca et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer

(2010) Jian-fang Liang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer

(2010) Yukiko Moriwaka et al.   PATHOBIOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY